logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

CU VENTURE INV (08159) announces a full-year net loss of HKD 4.268 million in 2024.

date
18/06/2025
avatar
GMT Eight
Xinhua United Investment (08159) announced its full-year performance for the 15 months ended March 31, 2024, with group revenue...
CU VENTURE INV (08159) announced its full-year performance for the 15-month period ending March 31, 2024. The group's revenue was HKD 209 million, with a net loss of HKD 4.268 million, resulting in a loss of 0.1 HK cents per share.
Related Articles
HK Stock Market Move | CHOW TAI FOOK (01929) rose by over 3% at the close. The company issued 8.8 billion Hong Kong dollars of convertible bonds to help reduce financing costs.
Tumor AI diagnosis platform Caris (CAI.US) raises its IPO price to $21, with a potential market value of $6.1 billion.
HK Stock Market Move | OCUMENSION-B(01477) rose more than 8%, the company continues to advance its innovative pipeline, and OT-802 has received CDE approval to conduct phase III clinical trials.
HK Stock Market Move | CHOW TAI FOOK (01929) rose by over 3% at the close. The company issued 8.8 billion Hong Kong dollars of convertible bonds to help reduce financing costs.
Tumor AI diagnosis platform Caris (CAI.US) raises its IPO price to $21, with a potential market value of $6.1 billion.
HK Stock Market Move | OCUMENSION-B(01477) rose more than 8%, the company continues to advance its innovative pipeline, and OT-802 has received CDE approval to conduct phase III clinical trials.
RECOMMEND
Goldman Sachs Introduces China’s “Top Ten Giants” to Rival the U.S. “Magnificent Seven”
Goldman Sachs Introduces China’s “Top Ten Giants” to Rival the U.S. “Magnificent Seven”
icon
17/06/2025
Government Subsidies and Pricing Tactics Draw Scrutiny During 618 Festival: Midea Accused of Price Manipulation
Government Subsidies and Pricing Tactics Draw Scrutiny During 618 Festival: Midea Accused of Price Manipulation
icon
17/06/2025
Profitability Remains Strong: Four Key Characteristics Behind Winning Hong Kong IPOs
Profitability Remains Strong: Four Key Characteristics Behind Winning Hong Kong IPOs
icon
17/06/2025
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.